Finished product reference
Naphazoline / Antazoline
Solution, Drops · Ophthalmic · 0.05 %/0.5 % · 10 mL
- List code
- 888
- Pharmacologic class
- Ophthalmic antihistamine and vasoconstrictor combination
What it is and how it works
Naphazoline is an alpha-adrenergic agonist that constricts conjunctival blood vessels, reducing redness and oedema; antazoline is an H1-antihistamine that reduces itching and lacrimation of allergic origin.
Indications
Short-term symptomatic relief of allergic and irritative conjunctivitis with redness, itching and watering.
Dosage and administration (summary)
1–2 drops into the affected eye(s) two to four times daily for a few days; not for prolonged use.
Contraindications
Narrow-angle glaucoma or predisposition to it; hypersensitivity; use with MAO inhibitors; young children (under 2 years per product).
Warnings and precautions
Prolonged or excessive use can cause rebound hyperaemia and conjunctivitis medicamentosa. Use with caution in hypertension, cardiovascular disease, hyperthyroidism and diabetes. Remove soft contact lenses before instillation if the product contains benzalkonium chloride.
Pregnancy
Avoid in pregnancy unless clearly necessary.
Storage and supply
Store below 25 °C, protected from light; discard 4 weeks after opening.
Source: reference summary prepared from the EU SmPC/EPAR, BNF and WHO Model Formulary. The approved product information in Iran governs.
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.